• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[胃肠功能障碍对帕金森病患者血浆左旋多巴浓度具有重要影响]

[Gastrointestinal dysfunction has important implications for plasma L-dopa concentrations in Parkinson's disease].

作者信息

Doi Hirokazu, Sakakibara Ryuji, Kishi Masahiko, Tsuyuzaki Yohei, Tateno Fuyuki, Hirai Shigekazu

机构信息

Pharmaceutical unit, Toho university Sakura medical center.

出版信息

Rinsho Shinkeigaku. 2013;53(11):1382-5. doi: 10.5692/clinicalneurol.53.1382.

DOI:10.5692/clinicalneurol.53.1382
PMID:24291998
Abstract

Gastrointestinal motility dysfunctions including anorexia, nausea, heartburn, bloating, etc. are common and frequent complication of Parkinson's disease (PD). Degeneration of enteric nerves system is supposed to be a pathogenesis of these symptoms. Impairment of gastric emptying (GE) leads to retardation of the drug delivery from stomach to jejunum, so that PD patients with GE impairment show the delayed elevation of plasma L-dopa concentration. Disturbance of L-dopa absorption will result in wearing-off and delayed-on, and these are called motor fluctuation. In our investigation, 69% of PD patients who exhibited delayed elevation of plasma L-dopa concentration complicated GE impairment, whereas only 22% of patients with normal L-dopa level showed GE retardation (p = 0.0044, χ(2)-test). Serotonin 5-HT4 agonist and dopamine D2 antagonist are useful to improve GE impairment in PD. These drugs stimulate the postganglionic cholinergic fiber to release acetylcholine amongst the enteric nerves system and facilitate the gastrointestinal tract. Rikkunshi-to, dietary herbal medicine, is also administered to ameliorate gastrointestinal symptoms in PD. Rikkunshi-to is reported to improve erratic GE and reduce the variation of plasma L-dopa level. Recently, intestinal continuous L-dopa administration is expected as the potential solution for L-dopa induced motor fluctuation in advanced PD.

摘要

胃肠动力功能障碍,包括厌食、恶心、烧心、腹胀等,是帕金森病(PD)常见且频发的并发症。肠神经系统变性被认为是这些症状的发病机制。胃排空(GE)受损会导致药物从胃到空肠的输送延迟,因此GE受损的PD患者血浆左旋多巴浓度升高延迟。左旋多巴吸收障碍会导致药效减退和起效延迟,这些被称为运动波动。在我们的研究中,血浆左旋多巴浓度升高延迟的PD患者中有69%并发GE受损,而左旋多巴水平正常的患者中只有22%出现GE延迟(p = 分)。血清素5-HT4激动剂和多巴胺D2拮抗剂有助于改善PD患者的GE受损。这些药物刺激节后胆碱能纤维在肠神经系统中释放乙酰胆碱,促进胃肠道蠕动。理气剂,一种膳食草药,也被用于改善PD患者的胃肠道症状。据报道,理气剂可改善不稳定的GE并减少血浆左旋多巴水平的波动。最近,肠道持续给予左旋多巴有望成为晚期PD患者左旋多巴诱发运动波动的潜在解决方案。

相似文献

1
[Gastrointestinal dysfunction has important implications for plasma L-dopa concentrations in Parkinson's disease].[胃肠功能障碍对帕金森病患者血浆左旋多巴浓度具有重要影响]
Rinsho Shinkeigaku. 2013;53(11):1382-5. doi: 10.5692/clinicalneurol.53.1382.
2
Is there a difference in gastric emptying between Parkinson's disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test.长期接受左旋多巴治疗的帕金森病患者中,有无运动波动者的胃排空是否存在差异?应用 13C-乙酸呼气试验的分析。
J Neurol. 2009 Dec;256(12):1972-6. doi: 10.1007/s00415-009-5220-5.
3
Gastric emptying time and gastric motility in patients with Parkinson's disease.帕金森病患者的胃排空时间和胃动力
Mov Disord. 2001 Nov;16(6):1041-7. doi: 10.1002/mds.1203.
4
Delayed Gastric Emptying in Advanced Parkinson Disease: Correlation With Therapeutic Doses.晚期帕金森病胃排空延迟:与治疗剂量的相关性。
Clin Nucl Med. 2017 Feb;42(2):83-87. doi: 10.1097/RLU.0000000000001470.
5
Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease.5-羟色胺4受体激动剂治疗期间胃动力增强可减少帕金森病的反应波动。
Parkinsonism Relat Disord. 2005 Dec;11(8):499-502. doi: 10.1016/j.parkreldis.2005.06.007. Epub 2005 Nov 2.
6
Levodopa and 3-OMD levels in Parkinson patients treated with Duodopa.帕金森病患者接受 Duodopa 治疗后的左旋多巴和 3-OMD 水平。
Eur Neuropsychopharmacol. 2010 Oct;20(10):683-7. doi: 10.1016/j.euroneuro.2010.04.010. Epub 2010 May 31.
7
Levodopa delivery systems: advancements in delivery of the gold standard.左旋多巴给药系统:金标准给药的进步。
Expert Opin Drug Deliv. 2010 Feb;7(2):203-24. doi: 10.1517/17425240903483166.
8
Irregular gastrointestinal drug absorption in Parkinson's disease.帕金森病中胃肠道药物吸收不规则。
Expert Opin Drug Metab Toxicol. 2008 Feb;4(2):193-203. doi: 10.1517/17425255.4.2.193.
9
Clinical implications of gastric complications on levodopa treatment in Parkinson's disease.帕金森病中胃部并发症对左旋多巴治疗的临床影响。
Parkinsonism Relat Disord. 2020 Jul;76:63-71. doi: 10.1016/j.parkreldis.2020.05.001. Epub 2020 May 11.
10
In vivo characterization of a novel dopamine D3 receptor agonist to treat motor symptoms of Parkinson's disease.一种用于治疗帕金森病运动症状的新型多巴胺D3受体激动剂的体内特性研究
Neuropharmacology. 2016 Jan;100:106-15. doi: 10.1016/j.neuropharm.2015.04.004. Epub 2015 Apr 18.

引用本文的文献

1
Correlation Between Lacunae and the Wearing-off Phenomenon in Parkinson's Disease.帕金森病中腔隙与剂末现象的相关性
Neuropsychiatr Dis Treat. 2022 Jan 11;18:67-74. doi: 10.2147/NDT.S342688. eCollection 2022.